REQUEST A DEMO
Total
USD $0.00
Search more companies

Heni Drugs Pvt Ltd (India)

Main Activities: Plastics Material and Resin Manufacturing
Full name: Heni Drugs Pvt Ltd Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Heni Drugs Pvt Ltd is an unlisted company, incorporated on 15/02/1993. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24139MH1993PTC070791 and registration number is 070791. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
26 Dream Land Vikramnear Shastri Nagar Mulund Colony
Mumbai; Maharashtra; Postal Code: 400082

Contact Details: Purchase the Heni Drugs Pvt Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Heni Drugs Pvt Ltd report to view the information.
Outstanding Shares:
Purchase the Heni Drugs Pvt Ltd report to view the information.
Registered Capital:
Purchase the Heni Drugs Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Heni Drugs Pvt Ltd report to view the information.
Incorporation Date:
February 15, 1993
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Heni Drugs Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
26.91%
Total operating revenue
27.17%
Operating profit (EBIT)
-1.23%
EBITDA
-0.15%
Net Profit (Loss) for the Period
29.74%
Total assets
7.26%
Total equity
19.74%
Operating Profit Margin (ROS)
-1.79%
Net Profit Margin
0.12%
Return on Equity (ROE)
1.27%
Debt to Equity Ratio
1.65%
Quick Ratio
0.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?